Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalyzed 1,4 Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105254657B details a rhodium-catalyzed route for prostaglandin analogs, offering milder conditions and reduced toxicity for reliable supply chain integration.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.